BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 6615267)

  • 1. EEG, transmission computed tomography, and positron emission tomography with fluorodeoxyglucose 18F. Their use in adults with gliomas.
    Newmark ME; Theodore WH; Sato S; De La Paz R; Patronas N; Brooks R; Jabbari B; Di Chiro G
    Arch Neurol; 1983 Oct; 40(10):607-10. PubMed ID: 6615267
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography.
    Di Chiro G; DeLaPaz RL; Brooks RA; Sokoloff L; Kornblith PL; Smith BH; Patronas NJ; Kufta CV; Kessler RM; Johnston GS; Manning RG; Wolf AP
    Neurology; 1982 Dec; 32(12):1323-9. PubMed ID: 6983044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors. A powerful diagnostic and prognostic tool.
    Di Chiro G
    Invest Radiol; 1987 May; 22(5):360-71. PubMed ID: 3496318
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tomographic mapping of rate constants of [F-18] FDG model].
    Sasaki H; Kanno I; Miura S; Murakami M; Takahashi K; Shishido F; Uemura K
    Kaku Igaku; 1985 Jan; 22(1):81-4. PubMed ID: 3873558
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of barbiturate coma on glucose utilization in normal brain versus gliomas. Positron emission tomography studies.
    Blacklock JB; Oldfield EH; Di Chiro G; Tran D; Theodore W; Wright DC; Larson SM
    J Neurosurg; 1987 Jul; 67(1):71-5. PubMed ID: 3496428
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Work in progress: [18F] fluorodeoxyglucose and positron emission tomography in the evaluation of radiation necrosis of the brain.
    Patronas NJ; Di Chiro G; Brooks RA; DeLaPaz RL; Kornblith PL; Smith BH; Rizzoli HV; Kessler RM; Manning RG; Channing M; Wolf AP; O'Connor CM
    Radiology; 1982 Sep; 144(4):885-9. PubMed ID: 6981123
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An analysis of 18FDG kinetic rate constants using dynamic positron emission tomography in human brain tumors].
    Yamaguchi T; Sasaki H; Uemura K; Shishido F; Inugami A; Ogawa T; Higano S; Mineura K; Kanno I; Murakami M
    Kaku Igaku; 1986 Jun; 23(6):829-32. PubMed ID: 3489854
    [No Abstract]   [Full Text] [Related]  

  • 8. [In vivo measurements of regional cerebral hemocirculation and metabolism in gliomas using 15O and 18F-fluorodeoxyglucose positron emission tomography].
    Mineura K; Yasuda T; Kowada M; Shishido F; Ogawa T; Uemura K
    No To Shinkei; 1986 Apr; 38(4):337-44. PubMed ID: 3013262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New grading system of cerebral gliomas using positron emission tomography with F-18 fluorodeoxyglucose.
    Kim CK; Alavi JB; Alavi A; Reivich M
    J Neurooncol; 1991 Feb; 10(1):85-91. PubMed ID: 2022975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypometabolic cortical lesions in tuberous sclerosis with epilepsy: demonstration by positron emission tomography.
    Szelies B; Herholz K; Heiss WD; Rackl A; Pawlik G; Wagner R; Ilsen HW; Wienhard K
    J Comput Assist Tomogr; 1983 Dec; 7(6):946-53. PubMed ID: 6415136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucose consumption and rate constants for 18F-fluorodeoxyglucose in human gliomas.
    Ishikawa M; Kikuchi H; Nagata I; Yamagata S; Taki W; Yonekura Y; Nishizawa S; Iwasaki Y; Mukai T
    Neurol Med Chir (Tokyo); 1990 Jun; 30(6):377-81. PubMed ID: 1700316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Positron emission tomography of fluorine-18-deoxyglucose and image-guided phosphorus-31 magnetic resonance spectroscopy in brain tumors.
    Heiss WD; Heindel W; Herholz K; Rudolf J; Bunke J; Jeske J; Friedmann G
    J Nucl Med; 1990 Mar; 31(3):302-10. PubMed ID: 2308001
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High [18F]FDG uptake in primary cerebral lymphoma: a PET study.
    Kuwabara Y; Ichiya Y; Otsuka M; Miyake Y; Gunasekera R; Hasuo K; Masuda K; Takeshita I; Fukui H
    J Comput Assist Tomogr; 1988; 12(1):47-8. PubMed ID: 3257221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positron emission tomography in patients with glioma. A predictor of prognosis.
    Alavi JB; Alavi A; Chawluk J; Kushner M; Powe J; Hickey W; Reivich M
    Cancer; 1988 Sep; 62(6):1074-8. PubMed ID: 3261622
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucose consumption in recurrent gliomas.
    Ishikawa M; Kikuchi H; Miyatake S; Oda Y; Yonekura Y; Nishizawa S
    Neurosurgery; 1993 Jul; 33(1):28-33. PubMed ID: 8355844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uncoupling of hexose transport and phosphorylation in human gliomas demonstrated by PET.
    Herholz K; Ziffling P; Staffen W; Pawlik G; Wagner R; Wienhard K; Heiss WD
    Eur J Cancer Clin Oncol; 1988 Jul; 24(7):1139-50. PubMed ID: 3262062
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose uptake by gliomas after treatment. A positron emission tomographic study.
    Rozental JM; Levine RL; Nickles RJ; Dobkin JA
    Arch Neurol; 1989 Dec; 46(12):1302-7. PubMed ID: 2556096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 11C-methionine and 18F-2-fluorodeoxyglucose positron emission tomography: a tool for diagnosis of cerebral glioma and monitoring after brachytherapy with 125I seeds.
    Voges J; Herholz K; Hölzer T; Würker M; Bauer B; Pietrzyk U; Treuer H; Schröder R; Sturm V; Heiss WD
    Stereotact Funct Neurosurg; 1997; 69(1-4 Pt 2):129-35. PubMed ID: 9711745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic imaging of the brain stem and spinal cord: studies with positron emission tomography using 18F-2-deoxyglucose in normal and pathological cases.
    Di Chiro G; Oldfield E; Bairamian D; Patronas NJ; Brooks RA; Mansi L; Smith BH; Kornblith PL; Margolin R
    J Comput Assist Tomogr; 1983 Dec; 7(6):937-45. PubMed ID: 6313774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes in glucose uptake by malignant gliomas: preliminary study of prognostic significance.
    Rozental JM; Levine RL; Nickles RJ
    J Neurooncol; 1991 Feb; 10(1):75-83. PubMed ID: 2022974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.